Results 81 to 90 of about 6,081 (225)

Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis

open access: yesChinese Medical Journal, 2019
. Background:. Previous studies on whether or not levosimendan improved the prognosis of patients with sepsis and septic shock have been inconsistent. We aimed to provide an updated analysis of the therapeutic value of levosimendan in adult patients with
Fang Feng   +6 more
doaj   +1 more source

Furosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline

open access: yes
ESC Heart Failure, Volume 12, Issue 4, Page 3200-3208, August 2025.
Massimo Mapelli   +9 more
wiley   +1 more source

An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer

open access: yesCurrent Issues in Molecular Biology
Cervical cancer presents a significant challenge to the global health of women. Despite substantial advances in human papillomavirus (HPV)-related cervical cancer vaccines, non-HPV-related cervical cancer is still waiting novel therapeutic options.
Zsuzsanna Schelz   +4 more
doaj   +1 more source

Levosimendan in sepsis [PDF]

open access: yesJournal of Clinical Intensive Care and Medicine, 2020
Ugur Koca, Burcu Tanay Demirdöven
openaire   +2 more sources

The effect of the calcium sensitizer levosimendan on the performance and the response to pacing of stunned myocardium in anaesthetized pigs [PDF]

open access: bronze, 2000
H. Schad   +6 more
openalex   +1 more source

Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts

open access: yesCardiovascular Diabetology, 2012
Background The authors examined whether milrinone and levosimendan could exert cardiac postconditioning effects in rats under normoglycemia and hyperglycemia, and whether the effects could be mediated by mitochondrial permeability transition pore (mPTP).
Matsumoto Shuhei   +6 more
doaj   +1 more source

Levosimendan For Post-Partum Cardiomyopathy

open access: yesCritical Care and Resuscitation, 2005
To describe the use of levosimendan, a novel inotropic agent, for the treatment of post-partum cardiomyopathy (PPCMO).The authors present the second recorded use of levosimendan for a woman with PPCMO.Levosimendan improved cardiac performance which was associated with symptomatic relief and echocardiographic improvement in ventricular function.
H D, Nguyen, B, McKeown
openaire   +2 more sources

Binding of Levosimendan, a Calcium Sensitizer, to Cardiac Troponin C [PDF]

open access: hybrid, 2001
Tia Sorsa   +11 more
openalex   +1 more source

Levosimendan in acute heart failure

open access: yesSigna Vitae, 2008
Numerous adverse effects and an increased mortality are the reasons why many clinicians are often unsuccessful with the inotropic agents presently in use. New therapeutic agents have been developed in the last few years to assist the clinician in the stabilization, support and treatment of cardiovascular disease.One of the newest groups of inotropic ...
HUSEDZINOVIC, INO   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy